Clinical Trial

Case Control in Sarcopenia Among Elderly Type 2 Diabetic Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. Assess sarcopenia prevalence in elderly diabetic patients. 2. Evaluate impact of diabetes and its medications on muscle health. 3. detect effect of sacropenia on quality of life on elderly
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Trial Details
NCT Number NCT07244601
Lead Sponsor Eman Alaa Eldean Mohamed
Conditions Sarcopenia
Enrollment 100 participants
Start Date 2025-12-22
Primary Completion 2027-10-20 (estimated)
Study Completion 2028-10-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-19